More coverage today.
The Sentiment: https://www.thesentiment.com.au/incannex-to-launch-world-first-magic-mushroom-trials-to-treat-anxiety/
Stock head: https://unauthorised investment advice/health/incannex-teams-with-monash-university-to-study-safety-and-efficacy-of-magic-mushroom-treatment/
Kalkine media: https://kalkinemedia.com/au/news/stock-market/incannex-asxihl-partners-with-monash-university-to-conduct-psilocybin-assisted-psychotherapy-trial
Money morning: https://www.moneymorning.com.au/20201208/incannex-healthcare-share-price-up-on-clinical-trial-asx-ihl.html
Eminetra: https://eminetra.com.au/can-magic-mushrooms-mdma-be-used-to-treat-anxiety-ptsd/82671/
acbnews (Chinese)- http://www.acbnews.com.au/companynews/20201208-57648.html
What will be interesting is US/ global coverage
